BETALOC

This brand name is authorized in Australia, Cyprus, Ecuador, Estonia, Hong Kong, Croatia, Ireland, Lithuania, Malta, Nigeria, New Zealand, Poland, Romania, United Kingdom

Active ingredients

The drug BETALOC contains one active pharmaceutical ingredient (API):

1 Metoprolol UNII W5S57Y3A5L - METOPROLOL TARTRATE

Metoprolol is a cardioselective beta-adrenergic blocking agent. It has a relatively greater blocking effect on beta1-receptors (ie those mediating adrenergic stimulation of heart rate and contractility and release of free fatty acids from fat stores) than on beta2-receptors, which are chiefly involved in broncho and vasodilation. Read about Metoprolol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BETALOC Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C07AB02	Metoprolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1324Q, 1325R
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.695-1-03-12, 27.741-1-03-12
Country: EE	Ravimiamet	Identifier(s): 1012835, 1019719, 1019720, 1029934, 1072066, 1072077, 1083406, 1083417, 1149061, 1149072, 1149106, 1149117, 1832576, 1832598, 1871906
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 36160
Country: HK	Department of Health Drug Office	Identifier(s): 19220, 19614, 19885, 30849, 30850, 34975, 49649
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-148642958, HR-H-495596644, HR-H-965178809
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1002098, 1002099, 1003719, 1004945, 1005306, 1005307, 1010461, 1019766, 1027886, 1027887, 1060286, 1060287, 1072191, 1085825, 1087050
Country: MT	Medicines Authority	Identifier(s): AA565/35601
Country: NG	Registered Drug Product Database	Identifier(s): A4-6202, A4-6203
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7035, 7037, 7038, 9518
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100009914, 100077784, 100077821, 100105948, 100254565, 100264931, 100264960, 100277738, 100277856, 100280120, 100296090, 100307988, 100310476, 100313658, 100314089, 100324521, 100325650, 100325667, 100333187, 100334146, 100336033, 100357839, 100358158, 100358170, 100360994, 100373904, 100374967, 100386500, 100387705, 100387734, 100400216, 100400506, 100400535, 100400676, 100400699, 100400995, 100403031, 100403522, 100403829, 100405691, 100405700, 100405975, 100413472, 100427600, 100435516, 100441379, 100444567, 100444886, 100448170, 100451176, 100454270, 100457646, 100462794, 100463582, 100468542
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66031001, W66032001, W66032002, W66032003, W66033001, W66033002, W66033003, W66034001, W66034002, W66034003, W66034004